Original Research
Published on 06 Oct 2021
Low GNG12 Expression Predicts Adverse Outcomes: A Potential Therapeutic Target for Osteosarcoma
in Cancer Immunity and Immunotherapy
- 6,336 views
- 15 citations
Original Research
Published on 06 Oct 2021
in Cancer Immunity and Immunotherapy
Original Research
Published on 16 Oct 2020
in Molecular Diagnostics and Therapeutics
Original Research
Published on 08 Jan 2021
in Signaling
Original Research
Published on 31 Oct 2024
in Thyroid Endocrinology
Original Research
Published on 16 Sep 2021
in Inflammation Pharmacology
Original Research
Published on 15 Sep 2022
in Cancer Immunity and Immunotherapy
Original Research
Published on 04 Mar 2019
in Epigenomics and Epigenetics
Original Research
Published on 28 Jun 2021
in Comparative Immunology
Original Research
Published on 18 Mar 2020
in Computational Genomics
Original Research
Published on 28 Jan 2021
in Cellular and Molecular Mechanisms of Brain-aging
Original Research
Published on 11 Mar 2022
in Comparative Immunology
Original Research
Published on 09 Nov 2022
in Cellular Biochemistry
Original Research
Published on 11 Mar 2021
in Molecular Diagnostics and Therapeutics
Original Research
Published on 26 Jan 2026
Original Research
Published on 05 Feb 2021
in Head and Neck Cancer
Original Research
Published on 13 Jan 2022
in Human and Medical Genomics